IP77-10: CD46 as a Theranostic Target in Bladder Cancer: Expression Profiling and Pre-Clinical Validation of [89Zr]Zr-DFO-YS5 PET in Bladder Cancer

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!